Objective： To evaluate the therapeutic effects of Quyu Xiaoban Capsule （祛瘀消斑胶带）, QYXBC） on endothelial dependent vascular relaxation （EDVR） function in patients with atherosclerosis （AS） with ultrasonic ...Objective： To evaluate the therapeutic effects of Quyu Xiaoban Capsule （祛瘀消斑胶带）, QYXBC） on endothelial dependent vascular relaxation （EDVR） function in patients with atherosclerosis （AS） with ultrasonic technique. Methods： Tested were the endothelial function and blood lipids of 42 patients with AS in the treated group and 30 healthy volunteers in the control group. And re-examination of these parameters was carried out on the AS patients after they had been treated with QYXBC for 10 months. Results： Before treatment, the reactive hyperemia induced changes in artery diameter in the treated group was significantly lower than that in the control group （P〈0.01）, while insignificant difference was found between the two groups in response to nitroglycerin. In the treated group after treatment, with D%-R improved significantly （P〈0.01）, total cholesterol （TC）, triglyceride （TG） and low-density lipoprotein cholesterol （LDL-C） decreased by 16.3%, 5.6%, 10.2% respectively and high-density lipoprotein cholesterol （HDL-C） increased by 7.5%. EDVR was correlated negatively with the serum TC, LDL-C concentrations and the baseline brachial diameter （D0） （r = -0.41, -0.66, -0.59, respectively, all P〈0.01）, but correlated positively with HDL-C （r=0.62, P〈0.05）. The ameliorative extent of EDVR was correlated positively to the decreased magnitude of TC and LDL-C concentrations （r = 0.67,0.59, both P〈0.01）. Conclusion： QYXBC can lower the level of blood lipids and improve significantly EDVR function.展开更多
基金Supported by the 9th 5-year Key Project of Shandong Provincial Ministry of Health (No. 9711)
文摘Objective： To evaluate the therapeutic effects of Quyu Xiaoban Capsule （祛瘀消斑胶带）, QYXBC） on endothelial dependent vascular relaxation （EDVR） function in patients with atherosclerosis （AS） with ultrasonic technique. Methods： Tested were the endothelial function and blood lipids of 42 patients with AS in the treated group and 30 healthy volunteers in the control group. And re-examination of these parameters was carried out on the AS patients after they had been treated with QYXBC for 10 months. Results： Before treatment, the reactive hyperemia induced changes in artery diameter in the treated group was significantly lower than that in the control group （P〈0.01）, while insignificant difference was found between the two groups in response to nitroglycerin. In the treated group after treatment, with D%-R improved significantly （P〈0.01）, total cholesterol （TC）, triglyceride （TG） and low-density lipoprotein cholesterol （LDL-C） decreased by 16.3%, 5.6%, 10.2% respectively and high-density lipoprotein cholesterol （HDL-C） increased by 7.5%. EDVR was correlated negatively with the serum TC, LDL-C concentrations and the baseline brachial diameter （D0） （r = -0.41, -0.66, -0.59, respectively, all P〈0.01）, but correlated positively with HDL-C （r=0.62, P〈0.05）. The ameliorative extent of EDVR was correlated positively to the decreased magnitude of TC and LDL-C concentrations （r = 0.67,0.59, both P〈0.01）. Conclusion： QYXBC can lower the level of blood lipids and improve significantly EDVR function.
